Mgat5 Deficiency in T Cells and Experimental Autoimmune Encephalomyelitis
Author(s) -
Ani Grigorian,
Michael Demetriou
Publication year - 2011
Publication title -
isrn neurology
Language(s) - English
Resource type - Journals
eISSN - 2090-5513
pISSN - 2090-5505
DOI - 10.5402/2011/374314
Subject(s) - experimental autoimmune encephalomyelitis , immunology , autoimmunity , autoimmune disease , encephalomyelitis , medicine , multiple sclerosis , immune system , antibody
Multiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disease initiated by autoreactive T cells. Mgat 5, a gene in the Asn (N-) linked protein glycosylation pathway, associates with MS severity and negatively regulates experimental autoimmune encephalomyelitis (EAE) and spontaneous inflammatory demyelination in mice. N-glycan branching by Mgat 5 regulates interaction of surface glycoproteins with galectins, forming a molecular lattice that differentially controls the concentration of surface glycoproteins. T-cell receptor signaling, T-cell proliferation, T H 1 differentiation, and CTLA-4 endocytosis are inhibited by Mgat 5 branching. Non-T cells also contribute to MS pathogenesis and express abundant Mgat 5 branched N-glycans. Here we explore whether Mgat 5 deficiency in myelin-reactive T cells is sufficient to promote demyelinating disease. Adoptive transfer of myelin-reactive Mgat5 −/− T cells into Mgat5 +/+ versus Mgat5 −/− recipients revealed more severe EAE in the latter, suggesting that Mgat 5 branching deficiency in recipient naive T cells and/or non-T cells contribute to disease pathogenesis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom